Items where authors include "Schmitt, L."

Article

Woods, B. orcid.org/0000-0002-7669-9415, Kearns, B., Schmitt, L. et al. (15 more authors) (2025) Assessing the value of new antimicrobials: evaluations of cefiderocol and ceftazidime-avibactam to inform delinked payments by the NHS in England. Applied Health Economics and Health Policy, 23 (1). pp. 5-17. ISSN 1175-5652

Harnan, S. orcid.org/0000-0002-9318-9206, Kearns, B. orcid.org/0000-0001-7730-668X, Scope, A. orcid.org/0000-0003-1604-1758 et al. (11 more authors) (2024) Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health Technology Assessment, 28 (73). ISSN 1366-5278

Woods, B. orcid.org/0000-0002-7669-9415, Schmitt, L. orcid.org/0000-0003-1052-488X, Jankovic, D. orcid.org/0000-0002-9311-1409 et al. (10 more authors) (2024) Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health Technology Assessment, 28 (28). pp. 1-238. ISSN 1366-5278